Prevalence of human parvovirus B19 in Chinese plasma pools for manufacturing plasma derivatives

BACKGROUND: Human parvovirus B19 (B19V) is a frequent contaminant of blood and plasma-derived medicinal products. To ensure the quality and safety of plasma-derived products, European regulations, Plasma Protein Therapeutics Association (PPTA) standard and FDA guidelines require testing of manufactu...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Virol J
Egile Nagusiak: Jia, Junting, Ma, Yuyuan, Zhao, Xiong, Guo, Yi, Huangfu, Chaoji, Fang, Chi, Fan, Rui, Lv, Maomin, Yin, Huiqiong, Zhang, Jingang
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2015
Gaiak:
Short Report
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4596515/
https://ncbi.nlm.nih.gov/pubmed/26445095
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12985-015-0396-z
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak